Antileishmanial activity against amastigote stage of Leishmania infantum infected in PMA-differentiated human THP1 cells assessed as inhibition of parasite growth at 0.5 uM after 72 hrs by Giemsa staining based light microscopy relative to control
Antileishmanial activity against amastigote stage of Leishmania infantum infected in PMA-differentiated human THP1 cells assessed as inhibition of parasite growth after 72 hrs by Giemsa staining based light microscopy
Selectivity index, ratio of IC50 for PMA-differentiated human THP1 cells to IC50 for amastigote stage of Leishmania infantum infected in PMA-differentiated human THP1 cells
Antileishmanial activity against Leishmania infantum MHOM/TN/1980/IPT-1 amastigotes infected in Balb/c mouse assessed as reduction in liver parasite load at 100 mg/kg, po administered for 4 days measured post last dose relative to control
Antileishmanial activity against Leishmania infantum MHOM/TN/1980/IPT-1 amastigotes infected in Balb/c mouse assessed as reduction in liver parasite load at 60 mg/kg, po administered for 4 days measured post last dose relative to control
Toxicity in Balb/c mouse infected with Leishmania infantum MHOM/TN/1980/IPT-1 amastigotes assessed as death at 100 mg/kg, administered for 4 days measured on day 10 to 12
Antileishmanial activity against Leishmania infantum MHOM/TN/1980/IPT-1 amastigotes infected in Balb/c mouse assessed as reduction in liver parasite load at 10 mg/kg, sc administered for 4 days measured post last dose relative to control
Antileishmanial activity against Leishmania infantum MHOM/TN/1980/IPT-1 amastigotes infected in Balb/c mouse assessed as reduction in liver parasite load at 5 mg/kg, sc administered for 5 days measured post last dose relative to control
Antileishmanial activity against Leishmania infantum MHOM/TN/1980/IPT-1 amastigotes infected in po dosed Balb/c mouse assessed as reduction in liver parasite load administered for 4 to 5 days measured post last dose
Antileishmanial activity against Leishmania infantum MHOM/TN/1980/IPT-1 amastigotes infected in sc dosed Balb/c mouse assessed as reduction in liver parasite load administered for 4 to 5 days measured post last dose